Cite
HARVARD Citation
Frater, J. et al. (2021). Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet. 8 (8), pp. e474-e485. [Online].